顺铂对肿瘤间充质干细胞中IL-6表达的调控及p38MAPK通路参与机制

doi:10.6040/j.issn.1671-7554.0.2018.1233

摘要/Abstract

摘要： 目的探讨顺铂(CDDP)对肿瘤间充质干细胞(MSCs)中白细胞介素-6(IL-6)表达的调控作用与参与机制。方法采用CDDP分别处理小鼠Lewis肺癌(LLC)细胞和MSCs,聚合酶链反应阵列(PCR Array)检测、筛选其IL-6表达改变,并通过实时荧光定量聚合酶链反应(qRT-PCR)、酶联免疫吸附实验(ELISA)等方法进一步验证。Western blotting检测CDDP处理后MSCs中p38MAPK通路的表达改变;并通过该通路特异性抑制剂抑制其激活,ELISA检测IL-6的表达。结果 CDDP处理LLC细胞后,IL-6的表达未见有统计学意义的改变(P>0.05)。PCR Array结果显示,CDDP处理MCSs 24 h后,各白细胞介素因子有不同程度的表达改变,其中IL-6表达上升最为显著;进一步研究证实,CDDP作用于MCSs 3、6和24 h后,IL-6 mRNA和蛋白表达均升高,差异具有统计学意义(IL-6 mRNA:P=0.218;P=0.007;P<0.001;蛋白表达:P=0.001;P<0.001;P<0.001)。CDDP处理后MSCs中p38和pp38的表达均明显增强,且pp38/p38比值明显升高;采用SB203580抑制p38MAPK通路后,CDDP所致的IL-6上调表达被部分逆转。结论 CDDP对LLC细胞中IL-6的表达无统计学意义影响,但可显著上调MSCs中IL-6的表达。CDDP处理后,MSCs中p38MAPK通路表达上调,抑制该通路后可下调IL-6的表达,提示CDDP可能通过p38MAPK通路调控IL-6在MSCs的表达。

关键词: 肺癌, 顺铂, 白细胞介素6, 间充质干细胞, p38MAPK通路

Abstract: Objective To investigate the effect of cisplatin(CDDP)on interleukin(IL)-6 expression in tumor mesenchymal stem cells(MSCs)and explore its possible mechanisms. Methods Lewis lung carcinoma(LLC)cells or MSCs were treated with CDDP, and their IL gene expression was detected by polymerase chain reaction array(PCR Array)and further verified by quantitative real-time polymerase chain reaction(qRT-PCR)and enzyme-linked immunosorbent assay(ELISA). After CDDP treatment, the activation of p38MAPK pathway in MSCs was analyzed by Western blotting. CDDP activated p38MAPK pathway was inhibited by the specific inhibitor, and IL-6 expression in MSCs was measured by ELISA. Results CDDP treatment showed no significant effect on the expression of IL-6 in LLC cells(P>0.05). However, IL gene expression was changed in MSCs treated with CDDP for 24 h, and IL-6 expression was increased most significantly. Further studies confirmed the increase of IL-6 mRNA and protein in MSCs after CDDP treatment for 3 h, 6 h and 24 h(P<0.05). Higher expressions of p38 and pp38 were detected in MSCs after CDDP treatment. Moreover, the ratio of pp38/p38 was significantly increased. After the p38MAPK pathway was inhibited by SB203580, the up-regulation of IL-6 caused by CDDP was partially reversed. Conclusion CDDP has no significant effect on IL-6 expression in LLC cells, but it significantly up-regulates the expression of IL-6 in MSCs. CDDP treatment activates the p38MAPK pathway in MSCs, and inhibiting this pathway resultes in down-regulation of IL-6. These results indicate that CDDP might regulate the expression of IL-6 in MSCs via the p38MAPK pathway.

Key words: Lung cancer, Cisplatin, Interleukin-6, Mesenchymal stem cells, p38MAPK pathway

中图分类号:

R734.2

张志慧,刘延国,肖丰启,马道新,王秀问. 顺铂对肿瘤间充质干细胞中IL-6表达的调控及p38MAPK通路参与机制[J]. 山东大学学报 (医学版), 2019, 57(3): 1-6.

ZHANG Zhihui, LIU Yanguo, XIAO Fengqi, MA Daoxin, WANG Xiuwen. Effect of cisplatin on IL-6 expression in tumor mesenchymal stem cells and underlying mechanism of p38MAPK pathway[J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 1-6.

参考文献

[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[2] 王善容, 丁月云, 朱宗平, 等. SPECT/CT融合骨显像诊断肺癌单发骨转移的价值[J]. 山东大学学报(医学版), 2018, 56(2):41-46. WANG Shanrong, DING Yueyun, ZHU Zongping, et al. Validity of SPECT/CT bone fusing imaging in the diagnosis of single bone metastasis of lung cancer[J]. Journal of Shandong University(Health Science), 2018, 56(2):41-46.
[3] Rossi A, Di Maio M. Platinum-based chemotherapy in advanced non-small-cell lung cancer:optimal number of treatment cycles[J]. Expert Rev Anticancer Ther, 2016, 16(6):653-660.
[4] 费成明, 常春康. 骨髓间充质干细胞介导恶性血液病耐药的研究进展[J]. 中华血液学杂志, 2018, 39(8):697-700. FEI Chengming, CHANG Chunkang. Bone marrow mesenchymal stromal cells mediated drug resistance in hematological malignancies[J]. Chinese Journal of Hematology, 2018, 39(8):697-700.
[5] Sun Y. Tumor microenvironment and cancer therapy resistance[J]. Cancer Lett, 2016, 380(1):205-215.
[6] Hui LL, Chen Y. Tumor microenvironment:Sanctuary of the devil[J]. Cancer Lett, 2015, 368(1):7-13.
[7] Melzer C, Yang YY, Hass R. Interaction of MSC with tumor cells[J]. Cell Commun Signal, 2016, 14(1):20. doi:10.1186/s12964-016-0143-0.
[8] Kraakman MJ, Kammoun HL, Allen TL, et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance[J]. Cell Metab, 2015, 21(3):403-416.
[9] Alspach E, Flanagan KC, Luo XM, et al. p38MAPK plays a crucial role in stromal-mediated tumorigenesis[J]. Cancer Discov, 2014, 4(6):716-729.
[10] Gupta J, del Barco Barrantes I, Igea A, et al. Dual function of p38α MAPK in colon cancer:suppression of colitis-associated tumor initiation but requirement for cancer cell survival[J]. Cancer Cell, 2014, 25(4):484-500.
[11] Ling WF, Zhang JM, Yuan ZR, et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment[J]. Cancer Res, 2014, 74(5):1576-1587.
[12] Ren GW, Zhang LY, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide[J]. Cell Stem Cell, 2008, 2(2):141-150.
[13] Zimmermann S, Dziadziuszko R, Peters S. Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases[J]. Cancer Treat Rev, 2014, 40(6):716-722.
[14] Wu T, Dai Y. Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387:61-68. doi:10.1016/j.canlet.2016.01.043.
[15] Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop:a driver of tumorigenesis[J]. Semin Immunol, 2014, 26(1):48-53.
[16] Nguyen DP, Li JY, Tewari AK. Inflammation and prostate cancer:the role of interleukin 6(IL-6)[J]. BJU Int, 2014, 113(6):986-992.
[17] Yao X, Huang JQ, Zhong HH, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J]. Pharmacol Ther, 2014, 141(2):125-139.
[18] Rossi JF, Lu ZY, Jourdan M, et al. Interleukin-6 as a therapeutic target[J]. Clin Cancer Res, 2015, 21(6):1248-1257.
[19] Davies R, Choy E. Clinical experience of IL-6 blockade in rheumatic diseases - implications on IL-6 biology and disease pathogenesis[J]. Semin Immunol, 2014, 26(1):97-104.
[20] Inoue N, Shimizu M, Tsunoda S, et al. Cytokine profile in adult-onset Still's disease:Comparison with systemic juvenile idiopathic arthritis[J]. Clin Immunol, 2016, 169:8-13. doi:10.1016/j.clim.2016.05.010.
[21] Melzer C, von der Ohe J, Hass R. Concise review:crosstalk of mesenchymal Stroma/Stem-like cells with cancer cells provides therapeutic potential[J]. Stem Cells, 2018, 36(7):951-968.
[22] Jones BE, Maerz MD, Buckner JH. IL-6:a cytokine at the crossroads of autoimmunity[J]. Curr Opin Immunol, 2018, 55:9-14. doi:10.1016/j.coi.2018.09.002.
[23] Jiang XY, Zhu XS, Liu N, et al. Diallyl trisulfide inhibits growth of NCI-H460 in Vitro and in Vivo, and ameliorates cisplatin-induced oxidative injury in the treatment of lung carcinoma in xenograft mice[J]. Int J Biol Sci, 2017, 13(2):167-178.
[24] Cuadrado A, Lafarga V, Cheung PC, et al. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis[J]. EMBO J, 2007, 26(8):2115-2126.
[25] Park GH, Park JH, Eo HJ, et al. The induction of activating transcription factor 3(ATF3)contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells[J]. BMC Complement Altern Med, 2014, 14:487. doi:10.1186/1472-6882-14-487.

相关文章 15

[1]	黄佩文, 王旭东. 治疗非小细胞肺癌新药:靶向c-Met蛋白的抗体药物偶联物Telisotuzumab Vedotin[J]. 山东大学学报 (医学版), 2026, 64(3): 124-130.
[2]	赵灿斌,邵将,管东辉,秦英,丁强,郭良,王伟伟,陈威,闫小龙,曾平. 木犀草素在炎症微环境下调控Wnt/β-catenin信号通路促进骨髓间充质干细胞成软骨分化的机制[J]. 山东大学学报 (医学版), 2025, 63(7): 11-22.
[3]	赵汉卿,周新睿,李子建,唐兴. 循环肿瘤细胞联合血清学检测在非小细胞肺癌中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 79-85.
[4]	徐年兴,魏东,乔俊杰,战炳炎. CD8⁺、IL-6和PaO₂对不可切除Ⅲ_B/C和Ⅳ期非小细胞肺癌免疫治疗触发放射召回性肺炎的预测价值[J]. 山东大学学报 (医学版), 2025, 63(2): 29-35.
[5]	山东省腔镜外科质量控制中心胸腔镜委员会. 山东省VATS/RATS非小细胞肺癌围术期质量控制指标专家共识(2025版)[J]. 山东大学学报 (医学版), 2025, 63(12): 1-5.
[6]	李懿原,马珊,李爱华,龙飞. 超声支气管镜引导下碘-125粒子植入治疗肺癌中央区淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(12): 26-34.
[7]	刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45.
[8]	刘海霞,皇甫莎莎,桑晓玉,崔东清,毕建忠,王萍. 间充质干细胞对实验性自身免疫性脑脊髓炎小鼠铁死亡的影响[J]. 山东大学学报 (医学版), 2024, 62(6): 1-8.
[9]	张荣雨,赵文,李洪欣,杨闯,王健,韩春燕,李际盛. 奥西替尼联合化疗一线治疗EGFR-RAD51融合突变转移性肺腺癌1例[J]. 山东大学学报 (医学版), 2024, 62(5): 116-120.
[10]	沈飞飞,李栋,刘玲红,鞠秀丽. 小肠黏膜下层处理的间充质干细胞片促进伤口愈合[J]. 山东大学学报 (医学版), 2024, 62(4): 68-77.
[11]	闫小龙,秦英,邵将,陈东峰,管东辉,赵灿斌. 姜黄素通过Wnt/β-catenin信号通路调控骨形成的机制[J]. 山东大学学报 (医学版), 2024, 62(10): 76-86.
[12]	王亚楠,梁传杰,贾梦琪,苑辉卿. 二硫键异构酶TMX1促进肺癌化疗耐药[J]. 山东大学学报 (医学版), 2023, 61(8): 31-39.
[13]	王蕾,向淇,刘学伍. 伴系统性硬化症、类风湿关节炎的副肿瘤神经综合征1例[J]. 山东大学学报 (医学版), 2023, 61(7): 118-120.
[14]	赵元元,路军涛,吴小华. 人脐带间充质干细胞外泌体miR-100对多囊卵巢综合征患者颗粒细胞炎症的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 51-58.
[15]	钟璐,薛付忠. 基于贝叶斯网络不确定性推理的肺癌风险预测模型[J]. 山东大学学报 (医学版), 2023, 61(4): 86-94.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed